Skip to content

A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00347997
Enrollment
0
Registered
2006-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2011-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Brief summary

A Study to demonstrate the safety and efficacy of wavefront laser refractive surgery treatments for myopia and astigmatism.

Interventions

DEVICE217z Laser

LASIK correction of myopia and myopic astigmatism

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Myopia with or without astigmatism.

Exclusion criteria

* Contraindications to LASIK.

Design outcomes

Primary

MeasureTime frame
Visual acuity24 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026